AskBio

AskBio

NC - Durham
Biotechnology

Focus: Cellular & Protein-Based Therapies

AskBio is a life sciences company focused on Cellular & Protein-Based Therapies.

Oncology
Employees
5000+
Open Jobs
39

Pipeline & Clinical Trials

This is an observational study.
Parkinson's Disease
N/A
Clinical Trials (1)
NCT05699460Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
N/A
N/A
Clinical Trials (1)
NCT07081841AB-1005 Long-Term Follow-up Study
N/A
ACTUS-101
Pompe Disease
Phase 1
Clinical Trials (1)
NCT03533673AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
Phase 1
3 x 10e13vg AB-1002
Congestive Heart Failure
Phase 1
Clinical Trials (1)
NCT04179643AB-1002 in Patients With Class III Heart Failure
Phase 1
Phase 1
Clinical Trials (1)
NCT04167540GDNF Gene Therapy for Parkinson's Disease
Phase 1
rAAV2.5-CMV-minidystrophin
Duchenne Muscular Dystrophy
Phase 1
Clinical Trials (1)
NCT00428935Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
Phase 1
AB-1003 dose level 1
Limb Girdle Muscular Dystrophy
Phase 1/2
Clinical Trials (1)
NCT05230459A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Phase 1/2
Clinical Trials (1)
NCT07282847A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)
Phase 1/2
AB-1001 Gene Therapy
Huntington Disease
Phase 1/2
Clinical Trials (1)
NCT05541627A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease
Phase 1/2
AAV2-GDNF gene therapy
Parkinson Disease
Phase 2
Clinical Trials (1)
NCT06285643A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
Phase 2
Prescriptive Infusion Algorithm
PARKINSON DISEASE (Disorder)
Phase 2
Clinical Trials (1)
NCT07215403Prescriptive Infusion Algorithm (PIA)
Phase 2
Clinical Trials (1)
NCT05598333Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
Phase 2

Open Jobs (39)

Interview Prep Quick Facts
Founded: 2020
Portfolio: 12 clinical trials
Top TAs: Neurology, Cardiovascular, Rare Diseases
Open Roles: 39 active jobs
Therapeutic Area Focus
Neurology
5 pipeline
Cardiovascular
2 pipeline
Rare Diseases
2 pipeline
Marketed
Pipeline

Hiring Trend

Stable
39
Open Roles
+2
Added
-2
Filled/Removed

Based on last 4 crawl cycles